Application of Nanotechnology for Sensitive Detection of Low-Abundance Single-Nucleotide Variations in Genomic DNA: A Review

Abstract

Single-nucleotide polymorphisms (SNPs) are the simplest and most common type of DNA variations in the human genome. This class of attractive genetic markers, along with point mutations, have been associated with the risk of developing a wide range of diseases, including cancer, cardiovascular diseases, autoimmune diseases, and neurodegenerative diseases. Several existing methods to detect SNPs and mutations in body fluids have faced limitations. Therefore, there is a need to focus on developing noninvasive future polymerase chain reaction (PCR)–free tools to detect low-abundant SNPs in such specimens. The detection of small concentrations of SNPs in the presence of a large background of wild-type genes is the biggest hurdle. Hence, the screening and detection of SNPs need efficient and straightforward strategies. Suitable amplification methods are being explored to avoid high-throughput settings and laborious efforts. Therefore, currently, DNA sensing methods are being explored for the ultrasensitive detection of SNPs based on the concept of nanotechnology. Owing to their small size and improved surface area, nanomaterials hold the extensive capacity to be used as biosensors in the genotyping and highly sensitive recognition of single-base mismatch in the presence of incomparable wild-type DNA fragments. Different nanomaterials have been combined with imaging and sensing techniques and amplification methods to facilitate the less time-consuming and easy detection of SNPs in different diseases. This review aims to highlight some of the most recent findings on the aspects of nanotechnology-based SNP sensing methods used for the specific and ultrasensitive detection of low-concentration SNPs and rare mutations.

Association of Polymorphisms in miR146a, an Inflammation-Associated MicroRNA, with the Risk of Idiopathic Recurrent Spontaneous Miscarriage: A Case-Control Study

“…Still, other mechanisms are involved in the pathogenesis of IRSM that remains to be fully elucidated. Such DNA variations might serve as a valuable prognostic factor to predict the risk of developing such gestational diseases and can be exploited in “Personalized Medicine” applications [ 67 , 68 ].…”

The Promise of Nanotechnology in Personalized Medicine

“…Further to a specific diagnosis, nanoparticles can provide a valuable tool to target the specific genetic abnormalities. Currently, it is possible to clinically test multigene panels for the patient and determine the decision on treatment for a particular drug [ 166 ].…”

Advances in early diagnosis of cervical cancer based on biosensors

“…Biosensors can be classified according to the different types of biological components or type of physicochemical transduction (Kamali et al, 2021; Karunakaran et al, 2015; Zandi, Rasooli, et al, 2021). Based on the transducer, these systems can be classified into optical, piezoelectric, magnetic, and electrochemical biosensors; in addition, fluorescence‐based assays, electrochemical‐based assays, enzyme‐linked immunosorbent assays, and mass‐based detection are the current methods used for detecting tumor markers (Laraib et al, 2021; Mukhtar et al, 2021; Rocha‐Santos, 2014; Sargazi, Fatima, et al, 2022). The current review aims to provide an overview of the advances in the field of biosensors for the diagnosis and detection of HPV as the causative agent of cervical cancer.…”